Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh (GILD34) Price & Analysis

― Followers

GILD34 Stock Chart & Stats

R$331.58

-R$0.60(-0.18%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week RangeR$0.01 - R$396.35

Previous CloseN/A

VolumeN/A

Average Volume (3M)221.00

Market Cap

R$821.34B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)16579.0

Beta-0.27

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding2,483,139,600

10 Day Avg. Volume337

30 Day Avg. Volume221

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh News

Gilead price target lowered to $145 from $155 at Barclays

Barclays lowered the firm’s price target on Gilead (GILD) to $145 from $155 and keeps an Equal Weight...

4d ago

GILD

Gilead price target lowered to $165 from $166 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Gilead (GILD) to $165 from $166 and keeps an Overweight...

6d ago

GILD

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

Gilead (GILD) Sciences announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European...

9d ago

MRK

GILD

Michael Yee Reiterates Buy on Gilead, Citing Long-Acting HIV Pipeline and PrEP Advancements as Drivers of Durable Growth

Analyst Michael Yee of UBS maintained a Buy rating on Gilead Sciences, with a price target of $175.00....

4d ago

GILD

GILD34 FAQ

What was Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s price range in the past 12 months?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh lowest stock price was R$0.01 and its highest was R$396.35 in the past 12 months.

What is Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s market cap?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s market cap is R$821.34B.

When is Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s earnings last quarter?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh released its earnings results on May 07, 2026. The company reported R$0.004 earnings per share for the quarter, beating the consensus estimate of N/A by R$0.004.

Is Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh overvalued?

According to Wall Street analysts Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh pay dividends?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh does not currently pay dividends.

What is Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s EPS estimate?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh have?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh has 2,483,139,600 shares outstanding.

What happened to Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh’s price movement after its last earnings report?

Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh reported an EPS of R$0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.831%.

Which hedge fund is a major shareholder of Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh?

Currently, no hedge funds are holding shares in BR:GILD34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology